Home > others & > L-Arginine HCl

L-Arginine HCl

盐酸L-精氨酸,L-Arg,(S)-(+)-Arginine hydrochloride

L-Arginine hydrochloride为合成一氧化氮的氮供体,是血管扩张剂。

目录号
EY0395
EY0395
纯度
99.38%
99.38%
规格
100 mg
500 mg
原价
112
335
售价
112
335
库存
现货
现货
订购
订购
订购
订购
订购
订购
  • 生物活性

    L-Arginine is the nitrogen donor for synthesis of nitric oxide, a potent vasodilator that is deficient during times of sickle cell crisis.

  • 体外研究

  • 体内研究

  • 激酶实验

  • 细胞实验

  • 动物实验

  • 不同实验动物依据体表面积的等效剂量转换表(数据来源于FDA指南)

    动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 AKm系数


    例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。


  • 参考文献

    [1] Vergnani L, et al. Circulation, 2000, 01(11), 1261-1266.
    [2] C B Christiansen et. Al. Hormone and Metabolic Research, 47(7), 537-543 (2015).
    [3] Rahul D Sheth et. Al. Biotechnology and Bioengineering, 111(8), 1595-1603 (2014).

    分子式
    C6H15ClN4O2
    分子量
    210.66
    CAS号
    1119-34-2
    储存方式
    ﹣20 ℃冷藏长期储存。冰袋运输
    溶剂(常温)
    DMSO
    <1 mg/mL
    Water
    >40 mg/mL
    Ethanol
    <1 mg/mL

    体内溶解度

  • Clinical Trial Information ( data from http://clinicaltrials.gov )

    NCT01775020 Sepsis|Septic Shock Dietary Supplement: L-arginine Maastricht University Medical Center|Novartis Medical Nutrition Early Phase 1 2003-10-01 2013-01-28
    NCT01796678 Vaso-occlusive Pain Episodes Drug: Arginine|Drug: Placebo Children's Hospital & Research Center Oakland Phase 2 2000-09-01 2013-07-29
    NCT01841281 Asthma|Inflammation Drug: L-Arginine|Drug: Placebo University of California, Davis|National Heart, Lung, and Blood Institute (NHLBI) Phase 2 2013-08-01 2016-12-19
    NCT01371357 Hyperhomocysteinemia Drug: TEST 1|Drug: TEST 2|Drug: TEST 3|Drug: TEST 4 Center for Health, Exercise and Sport Sciences, Serbia Phase 3 2011-05-01 2011-12-18
    NCT00876915 Venous Thromboembolism|Pulmonary Embolism Drug: dalteparin injection University of Rochester|National Heart, Lung, and Blood Institute (NHLBI)|Eisai Inc. Phase 3 2009-07-01 2015-10-28
    NCT02277184 Carcinoma, Squamous Cell of Head and Neck Drug: Ficlatuzumab|Drug: Cisplatin|Radiation: Intensity Modulated Radiotherapy (IMRT) Julie E. Bauman, MD, MPH|AVEO Pharmaceuticals, Inc.|University of Pittsburgh Phase 1 2015-09-01 2016-09-12
    NCT01566539 Healthy Drug: Intranasal Oxytocin|Drug: Intranasal Vasopressin 40 or 20 units|Drug: Intranasal Vasopressin|Drug: Intranasal Placebo OT Vehicle|Drug: Intranasal Placebo Saline|Drug: Intranasal Placebo AVP Vehicle|Drug: Lorazepam James K. Rilling, PhD|National Institute of Mental Health (NIMH)|John Templeton Foundation|Emory University 2008-04-01 2016-12-13

    注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。

  • 相关化合物库

  • 使用AMQUAR产品发表文献后请联系我们

相关推荐

X
  • 联系人 :
  • 收件地址 :
  • 电话号码 :
  • 单位名称 :
  • 产品货号 :
  • 产品规格 :
  • 发票抬头以及单位税号 :